Italian Study of Patients With Lymphoma

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

NCT06806488 ·Status: RECRUITING

Study on Plasmablastic Lymphoma Patients

NCT06781359 ·Status: RECRUITING

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

NCT05700149 ·Status: RECRUITING

A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients

NCT04139252 ·Status: UNKNOWN

An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program

NCT06782789 ·Status: RECRUITING

T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

NCT01142674 ·Status: COMPLETED

The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study

NCT05169203 ·Status: COMPLETED

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

NCT00949741 ·Status: COMPLETED

Multicenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting as Indolent Lymphoma

NCT06822829 ·Status: RECRUITING

Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen

NCT01478269 ·Status: COMPLETED

Bergamo Lymphoid Cancer Registry

NCT03131531 ·Status: RECRUITING

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

NCT05524298 ·Status: RECRUITING

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

NCT06008691 ·Status: RECRUITING

Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study

NCT05162170 ·Status: COMPLETED

Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life

NCT06026644 ·Status: ACTIVE_NOT_RECRUITING

Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma

NCT05422521 ·Status: RECRUITING ·Phase: NA

An Italian Experience on Grade 3b Follicular Lymphoma

NCT02927717 ·Status: UNKNOWN

Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

NCT06733987 ·Status: RECRUITING

Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

NCT04882475 ·Status: ACTIVE_NOT_RECRUITING

Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

NCT04298619 ·Status: COMPLETED

Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America

NCT02559583 ·Status: COMPLETED

Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma

NCT06761274 ·Status: RECRUITING ·Phase: NA

Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context

NCT06781450 ·Status: RECRUITING

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

NCT01110733 ·Status: COMPLETED

R-CHOP14 or R-CHOP21 &Consolidation PET-Oriented Radiotherapy (RT) in DLBCL Patients

NCT03364439 ·Status: COMPLETED ·Phase: PHASE2